Total Funding
62
63
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
128194
Op2Lysis develops drugs for hemorrhagic stroke patients.
About the Company
Op2Lysis is a neurotic drug developer working on a treatment for hemorrhagic stroke. The company's product is a thrombolytic drug that conveniently dissolves the intracerebral hematoma that occurs after a hemorrhagic stroke, allowing patients to avoid substantial disability and surgery. It was designed to be injected locally via a catheter
into the hematoma's core, using micro-invasive surgery.
